02.01.17
US Patent No. 9,526,689 B2; Mary Kay has patented a method of treating telangiectasia with a topical composition that is comprised of an alcoholic extract of Centella asiactica leaf; an aqueous extract of Vitis vinifera seed; an alcoholic, hydro-alcoholic, or aqueous extract of Magnolia grandiflora bark; an alcoholic, hydro-alcoholic, or aqueous extract of Camellia sinensis leaf; and dihydroxymethylchromone. The Centella asiactica leaf and Vitis vinifera seed extracts disrupt endothelia tubes in skin.
